Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Cradick

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 18, 2010
Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAsThomas J Cradick, Kathy Keck, Shannon Bradshaw, et al.
Nucleic Acids Research|January 2, 2014
An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavageEli J Fine, Thomas J Cradick, Charles L Zhao, et al.
Nucleic Acids Research|May 6, 2014
TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicityClaudio Mussolino, Jamal Alzubi, Eli J Fine, et al.
Biochemical and Biophysical Research Communications|August 11, 2006
Controlling gene expression in Drosophila using engineered zinc finger protein transcription factorsAndrew C Jamieson, Bo Guan, Thomas J Cradick, et al.
Nucleic Acids Research|January 21, 2014
SAPTA: a new design tool for improving TALE nuclease activityYanni Lin, Eli J Fine, Zhilan Zheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2015
Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human GenomeMaximilian Müller, Ciaran M Lee, Giedrius Gasiunas, et al.
Nucleic Acids Research|March 1, 2012
Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effectsCherie L Ramirez, Michael T Certo, Claudio Mussolino, et al.
Nucleic Acids Research|May 20, 2014
CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequencesYanni Lin, Thomas J Cradick, Matthew T Brown, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2025
Serum factors create species-specific barriers to hepatic gene transfer by lipid nanoparticles in liver-humanized miceDaniel Stone, Ryo Takeuchi, Harrison Dulin, et al.
Molecular Therapy. Methods & Clinical Development|December 13, 2021
<i>In vivo</i> genome editing at the albumin locus to treat methylmalonic acidemiaJessica L Schneller, Ciaran M Lee, Leah E Venturoni, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 18, 2010
Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAsThomas J Cradick, Kathy Keck, Shannon Bradshaw, et al.
Nucleic Acids Research|January 2, 2014
An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavageEli J Fine, Thomas J Cradick, Charles L Zhao, et al.
Nucleic Acids Research|May 6, 2014
TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicityClaudio Mussolino, Jamal Alzubi, Eli J Fine, et al.
Biochemical and Biophysical Research Communications|August 11, 2006
Controlling gene expression in Drosophila using engineered zinc finger protein transcription factorsAndrew C Jamieson, Bo Guan, Thomas J Cradick, et al.
Nucleic Acids Research|January 21, 2014
SAPTA: a new design tool for improving TALE nuclease activityYanni Lin, Eli J Fine, Zhilan Zheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2015
Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human GenomeMaximilian Müller, Ciaran M Lee, Giedrius Gasiunas, et al.
Nucleic Acids Research|March 1, 2012
Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effectsCherie L Ramirez, Michael T Certo, Claudio Mussolino, et al.
Nucleic Acids Research|May 20, 2014
CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequencesYanni Lin, Thomas J Cradick, Matthew T Brown, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2025
Serum factors create species-specific barriers to hepatic gene transfer by lipid nanoparticles in liver-humanized miceDaniel Stone, Ryo Takeuchi, Harrison Dulin, et al.
Molecular Therapy. Methods & Clinical Development|December 13, 2021
<i>In vivo</i> genome editing at the albumin locus to treat methylmalonic acidemiaJessica L Schneller, Ciaran M Lee, Leah E Venturoni, et al.
Pageof 3